Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.38 USD | -2.52% | -3.86% | +27.38% |
13/05 | Piper Sandler Adjusts Price Target on Myriad Genetics to $28 From $23, Maintains Neutral Rating | MT |
08/05 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.38% | 2.21B | |
-7.06% | 12.1B | |
-3.93% | 8.16B | |
+4.61% | 5.78B | |
+30.16% | 5.59B | |
-7.47% | 4.23B | |
-57.20% | 2.87B | |
+12.56% | 2.71B | |
-6.73% | 2.35B | |
-4.21% | 1.87B |
- Stock Market
- Equities
- MYGN Stock
- News Myriad Genetics, Inc.
- Myriad Genetics Narrows Q3 Adjusted Net Loss, Revenue Rises